Skip to main content
Top
Published in: Current Gastroenterology Reports 6/2010

01-12-2010

Diagnosis and Management of Pouchitis and Ileoanal Pouch Dysfunction

Authors: Udayakumar Navaneethan, Bo Shen

Published in: Current Gastroenterology Reports | Issue 6/2010

Login to get access

Abstract

Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) has become the surgical treatment of choice for patients with medically refractory ulcerative colitis (UC) or UC with dysplasia and for the majority of patients with familial adenomatous polyposis. However, UC patients with IPAA are susceptible to inflammatory and noninflammatory sequelae, such as pouchitis, Crohn’s disease of the pouch, cuffitis, and irritable pouch syndrome, in addition to common surgery-associated complications, which adversely affect the surgical outcome and compromise health-related quality of life. Pouchitis is the most frequent long-term complication of IPAA in patients with UC, with a cumulative prevalence of up to 50%. Pouchitis may be classified based on the etiology into idiopathic and secondary types, and the management is often different. Pouchoscopy is the most important tool for the diagnosis and differential diagnosis in patients with pouch dysfunction. Antibiotic therapy is the mainstay of treatment for active pouchitis. Some patients may develop dependency on antibiotics, requiring long-term maintenance therapy. Although management of antibiotic-dependent or antibiotic-refractory pouchitis has been challenging, secondary etiology for pouchitis should be evaluated and modified, if possible.
Literature
1.
go back to reference Fazio VW, Ziv Y, Church JM, et al.: Ileal pouch-anal anastomosis: complications and function in 1005 patients. Ann Surg 1995, 222:120–127.CrossRefPubMed Fazio VW, Ziv Y, Church JM, et al.: Ileal pouch-anal anastomosis: complications and function in 1005 patients. Ann Surg 1995, 222:120–127.CrossRefPubMed
2.
go back to reference Sandborn WJ: Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994, 107:1856–1860.PubMed Sandborn WJ: Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994, 107:1856–1860.PubMed
3.
go back to reference Coffey JC, Winter DC, Neary P, et al.: Quality of life after ileal pouch-anal anastomosis: an evaluation of diet and other factors using the Cleveland Global Quality of Life instrument. Dis Colon Rectum 2002, 45:30–38.PubMed Coffey JC, Winter DC, Neary P, et al.: Quality of life after ileal pouch-anal anastomosis: an evaluation of diet and other factors using the Cleveland Global Quality of Life instrument. Dis Colon Rectum 2002, 45:30–38.PubMed
4.
5.
go back to reference Hurst RD, Molinari M, Chung TP, et al.: Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996, 131:497–500; discussion 501–502.PubMed Hurst RD, Molinari M, Chung TP, et al.: Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996, 131:497–500; discussion 501–502.PubMed
6.
go back to reference Ohge H, Furne JK, Springfield J, et al.: Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005, 48:469–475.CrossRefPubMed Ohge H, Furne JK, Springfield J, et al.: Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005, 48:469–475.CrossRefPubMed
7.
go back to reference Gosselink MP, Schouten WR, van Lieshout LM, et al.: Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis Colon Rectum 2004, 47:1519–1525.CrossRefPubMed Gosselink MP, Schouten WR, van Lieshout LM, et al.: Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis Colon Rectum 2004, 47:1519–1525.CrossRefPubMed
8.
go back to reference Ohge H, Furne JK, Springfield J, et al.: Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005, 48:469–475.CrossRefPubMed Ohge H, Furne JK, Springfield J, et al.: Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005, 48:469–475.CrossRefPubMed
9.
go back to reference Falk A, Olsson C, Ahrne S, et al.: Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand J Gastroenterol 2007, 42:973–985.CrossRefPubMed Falk A, Olsson C, Ahrne S, et al.: Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand J Gastroenterol 2007, 42:973–985.CrossRefPubMed
10.
go back to reference •• Komanduri S, Gillevet PM, Sikaroodi M, et al.: Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol 2007, 5:352–360. This article describes a comprehensive study of microbiota using 16sRNA-based molecular microbiology in pouchitis patients.CrossRefPubMed •• Komanduri S, Gillevet PM, Sikaroodi M, et al.: Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol 2007, 5:352–360. This article describes a comprehensive study of microbiota using 16sRNA-based molecular microbiology in pouchitis patients.CrossRefPubMed
12.
go back to reference Ottesen EA, Hong JW, Quake SR, et al.: Microfluidic digital PCR enables multigene analysis of individual environmental bacteria. Science 2006, 314:1464–1467.CrossRefPubMed Ottesen EA, Hong JW, Quake SR, et al.: Microfluidic digital PCR enables multigene analysis of individual environmental bacteria. Science 2006, 314:1464–1467.CrossRefPubMed
13.
go back to reference Liu WT, Zhu L: Environmental microbiology-on-a-chip and its future impacts. Trends Biotechnol 2005, 23:174–179.CrossRefPubMed Liu WT, Zhu L: Environmental microbiology-on-a-chip and its future impacts. Trends Biotechnol 2005, 23:174–179.CrossRefPubMed
14.
go back to reference Marcy Y, Ouverney C, Bik EM, et al.: Dissecting biological “dark matter” with single-cell genetic analysis of rare and uncultivated TM7 microbes from the human mouth. Proc Natl Acad Sci U S A 2007, 104:11889–11894.CrossRefPubMed Marcy Y, Ouverney C, Bik EM, et al.: Dissecting biological “dark matter” with single-cell genetic analysis of rare and uncultivated TM7 microbes from the human mouth. Proc Natl Acad Sci U S A 2007, 104:11889–11894.CrossRefPubMed
15.
go back to reference •• Turroni S, Vitali B, Candela M, et al.: Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach. World J Gastroenterol 2010, 16:30–41. This article describes the first study to investigate the role of proteomics in chronic pouchitis.PubMed •• Turroni S, Vitali B, Candela M, et al.: Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach. World J Gastroenterol 2010, 16:30–41. This article describes the first study to investigate the role of proteomics in chronic pouchitis.PubMed
16.
go back to reference Kroesen AJ, Leistenschneider P, Lehmann K, et al.: Increased bacterial permeation in long-lasting ileoanal pouches. Inflamm Bowel Dis 2006, 12:736–744.CrossRefPubMed Kroesen AJ, Leistenschneider P, Lehmann K, et al.: Increased bacterial permeation in long-lasting ileoanal pouches. Inflamm Bowel Dis 2006, 12:736–744.CrossRefPubMed
17.
go back to reference DeSilva HJ, Jones M, Prince C, et al.: Lymphocyte and macrophage subpopulations in pelvic ileal reservoirs. Gut 1991, 32:1160–1165.CrossRef DeSilva HJ, Jones M, Prince C, et al.: Lymphocyte and macrophage subpopulations in pelvic ileal reservoirs. Gut 1991, 32:1160–1165.CrossRef
18.
go back to reference Hirata I, Berrebi G, Austin LL, et al.: Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and inflammatory bowel disease. Dig Dis Sci 1986, 31:593–603.CrossRefPubMed Hirata I, Berrebi G, Austin LL, et al.: Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and inflammatory bowel disease. Dig Dis Sci 1986, 31:593–603.CrossRefPubMed
19.
go back to reference • Navaneethan U, Shen B: Secondary pouchitis: those with identifiable etiopathogenetic or triggering factors. Am J Gastroenterol 2010, 105:51–64. This article presents a comprehensive review of the various causes of secondary pouchitis.CrossRefPubMed • Navaneethan U, Shen B: Secondary pouchitis: those with identifiable etiopathogenetic or triggering factors. Am J Gastroenterol 2010, 105:51–64. This article presents a comprehensive review of the various causes of secondary pouchitis.CrossRefPubMed
20.
go back to reference Casadesus D, Tani T, Wakai T, et al.: Possible role of human cytomegalovirus in pouchitis after proctocolectomy with ileal pouch-anal anastomosis in patients with ulcerative colitis. World J Gastroenterol 2007, 13:1085–1089.PubMed Casadesus D, Tani T, Wakai T, et al.: Possible role of human cytomegalovirus in pouchitis after proctocolectomy with ileal pouch-anal anastomosis in patients with ulcerative colitis. World J Gastroenterol 2007, 13:1085–1089.PubMed
21.
go back to reference •• Shen B, Jiang ZD, Fazio VW, et al.: Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008, 6:782–788. This article describes a very important study showing that C. difficile infection not only can occur in patients without a colon, but also can be common.CrossRefPubMed •• Shen B, Jiang ZD, Fazio VW, et al.: Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008, 6:782–788. This article describes a very important study showing that C. difficile infection not only can occur in patients without a colon, but also can be common.CrossRefPubMed
22.
go back to reference Shen B, Remzi FH, Nutter B, et al.: Association between Immune-associated disorders and adverse outcomes of Ileal pouch-anal anastomosis. Am J Gastroenterol 2009, 104:655–664.CrossRefPubMed Shen B, Remzi FH, Nutter B, et al.: Association between Immune-associated disorders and adverse outcomes of Ileal pouch-anal anastomosis. Am J Gastroenterol 2009, 104:655–664.CrossRefPubMed
23.
go back to reference • Shen B, Plesec TP, Remer E, et al.: Asymmetric endoscopic inflammation of the ileal pouch: a sign of ischemic pouchitis? Inflamm Bowel Dis 2010, 16:836–846. This article provides a description of ischemic pouchitis as a new disease entity.CrossRefPubMed • Shen B, Plesec TP, Remer E, et al.: Asymmetric endoscopic inflammation of the ileal pouch: a sign of ischemic pouchitis? Inflamm Bowel Dis 2010, 16:836–846. This article provides a description of ischemic pouchitis as a new disease entity.CrossRefPubMed
24.
25.
go back to reference Shen B, Fazio VW, Bennett AE, et al.: Effect of withdrawal of non-steroidal anti-inflammatory drug use in patients with the ileal pouch. Dig Dis Sci 2007, 52:3321–3328.CrossRefPubMed Shen B, Fazio VW, Bennett AE, et al.: Effect of withdrawal of non-steroidal anti-inflammatory drug use in patients with the ileal pouch. Dig Dis Sci 2007, 52:3321–3328.CrossRefPubMed
26.
go back to reference Sandborn WJ: Pouchitis: risk factors, frequency, natural history, classification and public health perspective. In Trends in Inflammatory Bowel Disease 1996. Edited by McLeod RS, Martin F, Sutherland LR, et al. Lancaster, UK: Kluwer Academic Publishers; 1997:51–63. Sandborn WJ: Pouchitis: risk factors, frequency, natural history, classification and public health perspective. In Trends in Inflammatory Bowel Disease 1996. Edited by McLeod RS, Martin F, Sutherland LR, et al. Lancaster, UK: Kluwer Academic Publishers; 1997:51–63.
27.
go back to reference Shen L, Lian L, Goldblum JR, Remzi FH: Development of de novo celiac disease after restorative proctocolectomy and ileal pouch-anal anastomosis. Inflamm Bowel Dis 2009, 15:1131–1132.CrossRefPubMed Shen L, Lian L, Goldblum JR, Remzi FH: Development of de novo celiac disease after restorative proctocolectomy and ileal pouch-anal anastomosis. Inflamm Bowel Dis 2009, 15:1131–1132.CrossRefPubMed
28.
go back to reference • Navaneethan U, Shen B: Pros and cons of antibiotic therapy for pouchitis. Expert Rev Gastroenterol Hepatol 2009, 3:547–359. This article provides a comprehensive review of risks and benefits of antibiotic use in pouchitis.CrossRefPubMed • Navaneethan U, Shen B: Pros and cons of antibiotic therapy for pouchitis. Expert Rev Gastroenterol Hepatol 2009, 3:547–359. This article provides a comprehensive review of risks and benefits of antibiotic use in pouchitis.CrossRefPubMed
29.
go back to reference Heuschen UA, Allemeyer EH, Hinz G, et al.: Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up. Dis Colon Rectum 2002, 45:776–786.CrossRefPubMed Heuschen UA, Allemeyer EH, Hinz G, et al.: Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up. Dis Colon Rectum 2002, 45:776–786.CrossRefPubMed
30.
go back to reference Shen B, Pardi DS, Bennett AE, et al.: The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis. Am J Gastroenterol 2009, 104:1468–1474.CrossRefPubMed Shen B, Pardi DS, Bennett AE, et al.: The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis. Am J Gastroenterol 2009, 104:1468–1474.CrossRefPubMed
31.
go back to reference •• Pardi DS, D’Haens G, Shen B, et al.: Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis 2009, 15:1424–1431. The authors present the only available guidelines on management of pouchitis.CrossRefPubMed •• Pardi DS, D’Haens G, Shen B, et al.: Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis 2009, 15:1424–1431. The authors present the only available guidelines on management of pouchitis.CrossRefPubMed
32.
go back to reference Shen B, Achkar J-P, Lashner BA, et al.: Endoscopic and histologic evaluations together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001, 121:261–267.CrossRefPubMed Shen B, Achkar J-P, Lashner BA, et al.: Endoscopic and histologic evaluations together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001, 121:261–267.CrossRefPubMed
33.
go back to reference Shen B, Achkar JP, Connor JT, et al.: Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003, 46:748–753.CrossRefPubMed Shen B, Achkar JP, Connor JT, et al.: Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003, 46:748–753.CrossRefPubMed
34.
go back to reference Sandborn WJ, Tremaine WJ, Batts KP, et al.: Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994, 69:409–415.PubMed Sandborn WJ, Tremaine WJ, Batts KP, et al.: Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994, 69:409–415.PubMed
35.
go back to reference Moskowitz RL, Shepherd NA, Nicholls RJ: An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986, 1:167–174.CrossRefPubMed Moskowitz RL, Shepherd NA, Nicholls RJ: An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986, 1:167–174.CrossRefPubMed
36.
go back to reference Shen B, Shermock KM, Fazio VW, et al.: A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2003, 98:2460–2467.PubMed Shen B, Shermock KM, Fazio VW, et al.: A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2003, 98:2460–2467.PubMed
37.
go back to reference Lohmuller JL, Pemberton HJ, Dozois RR, et al.: Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990, 211:622–629.PubMed Lohmuller JL, Pemberton HJ, Dozois RR, et al.: Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990, 211:622–629.PubMed
38.
go back to reference Wolf JM, Achkar JP, Lashner BA, et al.: Afferent limb ulcers predict Crohn’s disease in patients with ileal pouch-anal anastomosis. Gastroenterology 2004, 126:1686–1691.CrossRefPubMed Wolf JM, Achkar JP, Lashner BA, et al.: Afferent limb ulcers predict Crohn’s disease in patients with ileal pouch-anal anastomosis. Gastroenterology 2004, 126:1686–1691.CrossRefPubMed
39.
go back to reference Apel R, Cohen Z, Andrews CW Jr, et al.: Prospective evaluation of early morphological changes in pelvic ileal pouches. Gastroenterology 1994, 107:435–443.PubMed Apel R, Cohen Z, Andrews CW Jr, et al.: Prospective evaluation of early morphological changes in pelvic ileal pouches. Gastroenterology 1994, 107:435–443.PubMed
40.
go back to reference Veress B, Reinholt FP, Lindquist K, et al.: Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 1995, 109:1090–1097.CrossRefPubMed Veress B, Reinholt FP, Lindquist K, et al.: Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 1995, 109:1090–1097.CrossRefPubMed
41.
go back to reference Pardi DS, Sandborn WJ: Systematic review: the management of pouchitis. Aliment Pharmacol Ther 2006, 23:1087–1096.CrossRefPubMed Pardi DS, Sandborn WJ: Systematic review: the management of pouchitis. Aliment Pharmacol Ther 2006, 23:1087–1096.CrossRefPubMed
42.
go back to reference Navaneethan U, Shen B: Laboratory tests for patients with ileal pouch-anal anastomosis: clinical utility in predicting, diagnosing, and monitoring pouch disorders. Am J Gastroenterol 2009, 104:2606–2615.CrossRefPubMed Navaneethan U, Shen B: Laboratory tests for patients with ileal pouch-anal anastomosis: clinical utility in predicting, diagnosing, and monitoring pouch disorders. Am J Gastroenterol 2009, 104:2606–2615.CrossRefPubMed
43.
go back to reference Kuisma J, Nuutinen H, Luukkonen P, et al.: Long term metabolic consequences of ileal pouch–anal anastomosis for ulcerative colitis. Am J Gastroenterol 2001, 96:3110–3116.PubMed Kuisma J, Nuutinen H, Luukkonen P, et al.: Long term metabolic consequences of ileal pouch–anal anastomosis for ulcerative colitis. Am J Gastroenterol 2001, 96:3110–3116.PubMed
44.
go back to reference M’koma AE: Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy. Int J Colorectal Dis 2006, 21:711–720.CrossRefPubMed M’koma AE: Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy. Int J Colorectal Dis 2006, 21:711–720.CrossRefPubMed
45.
go back to reference Lu H, Lian L, Navaneethan U, Shen B: Clinical utility of C-reactive protein in patients with ileal pouch anal anastomosis. Inflamm Bowel Dis 2010 (Epub ahead of print). Lu H, Lian L, Navaneethan U, Shen B: Clinical utility of C-reactive protein in patients with ileal pouch anal anastomosis. Inflamm Bowel Dis 2010 (Epub ahead of print).
46.
go back to reference Walkowiak J, Banasiewicz T, Krokowicz P, et al.: Fecal pyruvate kinase (M2-PK): a new predictor for inflammation and severity of pouchitis. Scand J Gastroenterol 2005, 40:1493–1494.CrossRefPubMed Walkowiak J, Banasiewicz T, Krokowicz P, et al.: Fecal pyruvate kinase (M2-PK): a new predictor for inflammation and severity of pouchitis. Scand J Gastroenterol 2005, 40:1493–1494.CrossRefPubMed
47.
go back to reference Johnson MW, Maestranzi S, Duffy AM, et al.: Fecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol 2008, 20:174–179.CrossRefPubMed Johnson MW, Maestranzi S, Duffy AM, et al.: Fecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol 2008, 20:174–179.CrossRefPubMed
48.
go back to reference Parsi M, Shen B, Achkar J, et al.: Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology 2004, 126:1280–1286.CrossRefPubMed Parsi M, Shen B, Achkar J, et al.: Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology 2004, 126:1280–1286.CrossRefPubMed
49.
go back to reference Lim M, Gonsalves S, Thekkinkattil D, et al.: The assessment of a rapid noninvasive immunochromatographic assay test for fecal lactoferrin in patients with suspected inflammation of the ileal pouch. Dis Colon Rectum 2008, 51:96–99.CrossRefPubMed Lim M, Gonsalves S, Thekkinkattil D, et al.: The assessment of a rapid noninvasive immunochromatographic assay test for fecal lactoferrin in patients with suspected inflammation of the ileal pouch. Dis Colon Rectum 2008, 51:96–99.CrossRefPubMed
50.
go back to reference Melmed GY, Fleshner PR, Bardakcioglu O, et al.: Family history and serology predict Crohn’s disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2008, 51:100–108.CrossRefPubMed Melmed GY, Fleshner PR, Bardakcioglu O, et al.: Family history and serology predict Crohn’s disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2008, 51:100–108.CrossRefPubMed
51.
go back to reference Tang L, Boone J, Moore L, et al.: Clinical significance of stool ASCA in disorders of the ileal pouch [abstract]. Inflamm Bowel Dis 2008, 12: S2. Tang L, Boone J, Moore L, et al.: Clinical significance of stool ASCA in disorders of the ileal pouch [abstract]. Inflamm Bowel Dis 2008, 12: S2.
52.
go back to reference Shen B: Campylobacter infection in patients with ileal pouches. Am J Gastroenterol 2010, 105:472–473.CrossRefPubMed Shen B: Campylobacter infection in patients with ileal pouches. Am J Gastroenterol 2010, 105:472–473.CrossRefPubMed
53.
go back to reference • McLaughlin SD, Clark SK, Shafi S, et al.: Fecal coliform testing to identify effective antibiotic therapies for patients with antibiotic-resistant pouchitis. Clin Gastroenterol Hepatol 2009, 7:545–548. This article describes the first study to report the use of fecal coliform testing for treating patients with antibiotic-resistant pouchitis.CrossRefPubMed • McLaughlin SD, Clark SK, Shafi S, et al.: Fecal coliform testing to identify effective antibiotic therapies for patients with antibiotic-resistant pouchitis. Clin Gastroenterol Hepatol 2009, 7:545–548. This article describes the first study to report the use of fecal coliform testing for treating patients with antibiotic-resistant pouchitis.CrossRefPubMed
54.
go back to reference Seggerman RE, Chen MY, Waters GS, Ott DJ: Radiology of ileal pouch-anal anastomosis surgery. AJR Am J Roentgenol 2003, 180:999–1002.PubMed Seggerman RE, Chen MY, Waters GS, Ott DJ: Radiology of ileal pouch-anal anastomosis surgery. AJR Am J Roentgenol 2003, 180:999–1002.PubMed
55.
go back to reference Shen B, Fazio VW, Remzi FH, et al.: Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol 2005, 100:93–101.CrossRefPubMed Shen B, Fazio VW, Remzi FH, et al.: Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol 2005, 100:93–101.CrossRefPubMed
56.
go back to reference Shepherd NA, Hulten L, Tytgat GN, et al.: Workshop: pouchitis. Int J Colorectal Dis 1989, 4:205–229.CrossRefPubMed Shepherd NA, Hulten L, Tytgat GN, et al.: Workshop: pouchitis. Int J Colorectal Dis 1989, 4:205–229.CrossRefPubMed
57.
58.
go back to reference Madden MV, McIntyre AS, Nicholls RJ: Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994, 39:1193–1196.CrossRefPubMed Madden MV, McIntyre AS, Nicholls RJ: Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994, 39:1193–1196.CrossRefPubMed
59.
go back to reference Shen B, Achkar JP, Lashner BA, et al.: A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001, 7:301–305.CrossRefPubMed Shen B, Achkar JP, Lashner BA, et al.: A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001, 7:301–305.CrossRefPubMed
60.
go back to reference Pepin J, Saheb N, Coulombe MA, et al.: Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile–associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005, 41:1254–1260.CrossRefPubMed Pepin J, Saheb N, Coulombe MA, et al.: Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile–associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005, 41:1254–1260.CrossRefPubMed
61.
go back to reference Isaacs KL, Sandler RS, Abreu M, et al.: Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2007, 13:1250–1255.CrossRefPubMed Isaacs KL, Sandler RS, Abreu M, et al.: Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2007, 13:1250–1255.CrossRefPubMed
62.
go back to reference Shen B, Remzi FH, Lopez AR, Queener E: Rifaximin for maintenance therapy in antibiotic-dependent pouchitis. BMC Gastroenterol 2008, 8:26.CrossRefPubMed Shen B, Remzi FH, Lopez AR, Queener E: Rifaximin for maintenance therapy in antibiotic-dependent pouchitis. BMC Gastroenterol 2008, 8:26.CrossRefPubMed
63.
go back to reference Shen B, Fazio V, Remzi F, et al.: Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Col Rectum 2007, 50:498–508.CrossRef Shen B, Fazio V, Remzi F, et al.: Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Col Rectum 2007, 50:498–508.CrossRef
64.
go back to reference • Ha CY, Bauer JJ, Lazarev M, et al.: Early institution of tinidazole may prevent pouchitis following ileal-pouch anal anastomosis (IPAA) surgery in ulcerative colitis (UC) patients [abstract]. Gastroenterology 2010, 138:S69. The authors describe a randomized, controlled trial of tinidazole in preventing pouchitis after IPAA surgery. • Ha CY, Bauer JJ, Lazarev M, et al.: Early institution of tinidazole may prevent pouchitis following ileal-pouch anal anastomosis (IPAA) surgery in ulcerative colitis (UC) patients [abstract]. Gastroenterology 2010, 138:S69. The authors describe a randomized, controlled trial of tinidazole in preventing pouchitis after IPAA surgery.
65.
go back to reference Gionchetti P, Rizzello F, Helwig U, et al.: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003, 124:1202–1209.CrossRefPubMed Gionchetti P, Rizzello F, Helwig U, et al.: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003, 124:1202–1209.CrossRefPubMed
66.
go back to reference Gionchetti P, Rizzello F, Venturi A, et al.: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:305–309.CrossRefPubMed Gionchetti P, Rizzello F, Venturi A, et al.: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:305–309.CrossRefPubMed
67.
go back to reference Elahi B, Nikfar S, Derakhshani S, et al.: On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig Dis Sci 2008, 53:1278–1284.CrossRefPubMed Elahi B, Nikfar S, Derakhshani S, et al.: On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig Dis Sci 2008, 53:1278–1284.CrossRefPubMed
68.
go back to reference Shen B, Remzi FH, Lavery IC, et al.: Administration of adalimumab in the treatment of Crohn’s disease of the ileal pouch. Aliment Pharmacol Ther 2009, 29:519–526.CrossRefPubMed Shen B, Remzi FH, Lavery IC, et al.: Administration of adalimumab in the treatment of Crohn’s disease of the ileal pouch. Aliment Pharmacol Ther 2009, 29:519–526.CrossRefPubMed
69.
go back to reference Wischmeyer P, Pemberton JH, Phillips SF: Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993, 68:978–981.PubMed Wischmeyer P, Pemberton JH, Phillips SF: Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993, 68:978–981.PubMed
70.
go back to reference Tremaine WJ, Sandborn WJ, Wolff BG, et al.: Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997, 11:1041–106.CrossRefPubMed Tremaine WJ, Sandborn WJ, Wolff BG, et al.: Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997, 11:1041–106.CrossRefPubMed
Metadata
Title
Diagnosis and Management of Pouchitis and Ileoanal Pouch Dysfunction
Authors
Udayakumar Navaneethan
Bo Shen
Publication date
01-12-2010
Publisher
Current Science Inc.
Published in
Current Gastroenterology Reports / Issue 6/2010
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-010-0143-y

Other articles of this Issue 6/2010

Current Gastroenterology Reports 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine